Amid dra­ma, Cutera toss­es out CEO and chair, ap­points re­place­ments

A medtech com­pa­ny has ter­mi­nat­ed two of its top ex­ec­u­tives “for cause,” ap­point­ing an in­ter­im CEO amidst dra­ma over com­pa­ny con­trol and a sub­stan­tial drop in its stock price.

Cutera, which fo­cus­es on med­ical de­vices em­pha­siz­ing aes­thet­ics and der­ma­tol­ogy, said Wednes­day that it has made one of its board di­rec­tors, for­mer Bausch + Lomb EVP Sheila Hop­kins, its in­ter­im CEO, ef­fec­tive im­me­di­ate­ly. Ad­di­tion­al­ly, board mem­ber Janet Wid­mann has been made in­de­pen­dent chair.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER